General Prognostics (GPx)

📍 Boston, United States🗓 Founded 2020👥 5 employees💰 Last funded 2021
General Prognostics (GPx) is revolutionizing remote chronic disease management with the world's first bloodless blood tests. Headquartered in Boston, MA, GPx is dedicated to transforming the standard of care of cardiorenal diseases and enabling patients to better understand their condition, much like the continuous glucose monitor has transformed diabetes care.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in General Prognostics (GPx)?
General Prognostics (GPx) has 1 investors on record on gritt.io, including 1 early-stage backers.
When did General Prognostics (GPx) last raise funding?
The most recent investment in General Prognostics (GPx) recorded on gritt.io was in 2021.
When was General Prognostics (GPx) founded?
General Prognostics (GPx) was founded in 2020.
What industry is General Prognostics (GPx) in?
General Prognostics (GPx) operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is General Prognostics (GPx) based?
General Prognostics (GPx) is headquartered in Boston, United States.